<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2017.01841</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Deletion of the <sc>L</sc>-Lactate Dehydrogenase Gene <italic>ldh</italic> in <italic>Streptococcus pyogenes</italic> Leads to a Loss of SpeB Activity and a Hypovirulent Phenotype</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Oehmcke-Hecht</surname> <given-names>Sonja</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/317449/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Nass</surname> <given-names>Leif E.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wichura</surname> <given-names>Jan B.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mikkat</surname> <given-names>Stefan</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/468074/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kreikemeyer</surname> <given-names>Bernd</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/171026/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Fiedler</surname> <given-names>Tomas</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/196272/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Institute of Medical Microbiology, Virology, and Hygiene, Rostock University Medical Centre</institution> <country>Rostock, Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Core Facility Proteome Analysis, Rostock University Medical Centre</institution> <country>Rostock, Germany</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: <italic>Fumito Maruyama, Kyoto University, Japan</italic></p></fn>
<fn fn-type="edited-by"><p>Reviewed by: <italic>Maren Von K&#x00F6;ckritz-Blickwede, University of Veterinary Medicine Hannover, Germany; Shivangi Agarwal, Northwestern University, United States</italic></p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x002A;Correspondence: <italic>Tomas Fiedler, <email>tomas.fiedler@med.uni-rostock.de</email></italic></p></fn>
<fn fn-type="other" id="fn002"><p>This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>09</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>1841</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>07</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>09</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2017 Oehmcke-Hecht, Nass, Wichura, Mikkat, Kreikemeyer and Fiedler.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Oehmcke-Hecht, Nass, Wichura, Mikkat, Kreikemeyer and Fiedler</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p><italic>Streptococcus pyogenes</italic> uses lactic acid fermentation for the generation of ATP. Here, we analyzed the impact of a deletion of the <sc>L</sc>-lactate dehydrogenase gene <italic>ldh</italic> on the virulence of <italic>S. pyogenes</italic> M49. While the <italic>ldh</italic> deletion does not cause a general growth deficiency in laboratory media, the growth in human blood and plasma is significantly hampered. The <italic>ldh</italic> deletion strain is furthermore less virulent in a <italic>Galleria mellonella</italic> infection model. We show that the <italic>ldh</italic> deletion leads to a decrease in the activity of the cysteine protease SpeB, an important secreted virulence factor of <italic>S. pyogenes</italic>. The reduced SpeB activity is caused by a hampered autocatalytic activation of the SpeB zymogen into the mature SpeB. The missing SpeB activity furthermore leads to increased plasmin activation and a reduced activation of the contact system on the surface of <italic>S. pyogenes</italic>. All these effects can be reversed when <italic>ldh</italic> is reintroduced into the mutant via a plasmid. The results demonstrate a previously unappreciated role for LDH in modulation of SpeB maturation.</p>
</abstract>
<kwd-group>
<kwd>SpeB</kwd>
<kwd>LDH</kwd>
<kwd><italic>Galleria mellonella</italic></kwd>
<kwd><italic>Streptococcus pyogenes</italic></kwd>
<kwd>contact system</kwd>
</kwd-group>
<contract-num rid="cn001">SysMO-LAB</contract-num>
<contract-num rid="cn001">SysMO-LAB2</contract-num>
<contract-sponsor id="cn001">Bundesministerium f&#x00FC;r Bildung und Forschung<named-content content-type="fundref-id">10.13039/501100002347</named-content></contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="52"/>
<page-count count="9"/>
<word-count count="0"/>
</counts>
</article-meta>
</front>
<body>
<sec><title>Introduction</title>
<p><italic>Streptococcus pyogenes</italic> (group A streptococcus, GAS) is an important human pathogen. It is equipped with a large number of virulence factors. The expression of these virulence factors is tightly controlled by a complex network of regulatory proteins and sRNAs (<xref ref-type="bibr" rid="B13">Fiedler et al., 2010</xref>; <xref ref-type="bibr" rid="B44">Patenge et al., 2013</xref>; <xref ref-type="bibr" rid="B52">Walker et al., 2014</xref>). Taxonomically, GAS belongs to the Lactobacillales meaning that it converts carbohydrates to lactic acid. In lactic acid bacteria, the major enzyme responsible for pyruvate degradation and recycling of the NAD<sup>+</sup> reduced during glycolysis is <sc>L</sc>-lactate dehydrogenase (<xref ref-type="bibr" rid="B12">Fiedler et al., 2011</xref>; <xref ref-type="bibr" rid="B26">Levering et al., 2012</xref>, <xref ref-type="bibr" rid="B25">2016</xref>; <xref ref-type="bibr" rid="B11">Feldman-Salit et al., 2013</xref>). In a previous study, we could show that deletion of the <sc>L</sc>-lactate dehydrogenase gene in GAS M49 strain 591 does not affect the growth of the bacteria in complex or chemically defined laboratory media. The bacteria are simply switching their metabolism from homofermentative lactate production to the mixed acid branch with production of ethanol, acetate, formate, and an additional ATP per glucose (<xref ref-type="bibr" rid="B12">Fiedler et al., 2011</xref>). Here, we show that the deletion of the <italic>ldh</italic> gene in GAS M49 strain 591 leads to a significant loss of fitness in human blood or plasma, a decreased contact system activation on the bacterial surface, an increased plasmin/streptokinase (Ska) activity and decreased virulence in a <italic>Galleria mellonella</italic> infection model. We show that this phenotype can be explained by the loss of activity of the streptococcal cysteine protease SpeB in the <italic>ldh</italic> deletion strain.</p>
<p>The GAS protein originally named streptococcal pyrogenic exotoxin B (SpeB) is neither pyrogenic nor is it an exotoxin. Instead, it is a potent secreted cysteine protease and an important virulence factor in GAS (<xref ref-type="bibr" rid="B38">Nelson et al., 2011</xref>). The <italic>speB</italic> gene is transcribed as a bicistronic mRNA with the <italic>spi</italic> gene encoding the SpeB inhibitor protein Spi (<xref ref-type="bibr" rid="B20">Kagawa et al., 2005</xref>). Intracellularly, Spi probably prevents SpeB from cleaving cytoplasmic GAS proteins (<xref ref-type="bibr" rid="B20">Kagawa et al., 2005</xref>). Extracellularly, SpeB is activated from its 40 kDa zymogen into an active 28 kDa enzyme by autocatalytic cleavage under reducing conditions (<xref ref-type="bibr" rid="B10">Doran et al., 1999</xref>). The mechanisms triggering the activation process are not fully understood. There is experimental evidence that cell wall-anchored M protein is involved in the activation of SpeB into the mature enzyme (<xref ref-type="bibr" rid="B5">Collin and Ols&#x00E9;n, 2000</xref>). SpeB has been shown to cleave immunoglobulins, complement factors, and numerous host matrix and plasma proteins (<xref ref-type="bibr" rid="B21">Kapur et al., 1993a</xref>,<xref ref-type="bibr" rid="B22">b</xref>; <xref ref-type="bibr" rid="B18">Herwald et al., 1996</xref>; <xref ref-type="bibr" rid="B6">Collin and Ols&#x00E9;n, 2001</xref>; <xref ref-type="bibr" rid="B50">Terao et al., 2008</xref>; <xref ref-type="bibr" rid="B19">Honda-Ogawa et al., 2013</xref>). Among the plasma proteins degraded by SpeB is high molecular weight kininogen (HK), a component of the human contact system (<xref ref-type="bibr" rid="B18">Herwald et al., 1996</xref>). The contact system, also known as the intrinsic pathway of coagulation, consists of four proteins, factor XI, factor XII (FXII), plasma kallikrein (PK) and HK (<xref ref-type="bibr" rid="B14">Frick et al., 2006</xref>). FXII is activated on negatively charged surfaces. Activated FXII activates (i) factor XIa which triggers the intrinsic pathway of coagulation, and (ii) prekallikrein into PK which cleaves HK into kinins, e.g., the proinflammatory bradykinin, and smaller peptides, e.g., the antimicrobially active NAT26 (<xref ref-type="bibr" rid="B14">Frick et al., 2006</xref>). Prekallikrein can also be activated by the plasma protease plasmin. The activation of plasminogen into plasmin is usually mediated by human tissue or urokinase plasmin activators tPA and uPA, but can also be activated via Ska, another secreted GAS virulence factor (<xref ref-type="bibr" rid="B41">Nitzsche et al., 2015</xref>). SpeB potently degrades Ska, thereby reducing plasmin activity (<xref ref-type="bibr" rid="B49">Svensson et al., 2002</xref>). Furthermore, bacteria can directly interact with different contact system components (<xref ref-type="bibr" rid="B40">Nickel and Renne, 2012</xref>). GAS can bind HK via the M protein and cleave it via SpeB (<xref ref-type="bibr" rid="B1">Ben Nasr et al., 1997</xref>). Hence, there is a complex network of interactions of GAS with coagulation factors and, consequently, with hemostasis in the human host.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec><title>Bacterial Strains and Culture Conditions</title>
<p>The <italic>S. pyogenes</italic> serotype M49 wild type (WT) strain 591 was obtained from R. L&#x00FC;tticken (Aachen). The <sc>L</sc>-lactate production deficient mutant (&#x0394;<italic>ldh</italic>) of <italic>S. pyogenes</italic> M49 has been described previously (<xref ref-type="bibr" rid="B12">Fiedler et al., 2011</xref>). Generally, bacteria were grown in Todd Hewitt broth (Oxoid) supplemented with 0.5% yeast extract (THY; Oxoid) at 37&#x00B0;C in a 5% CO<sub>2</sub>/20% O<sub>2</sub> atmosphere.</p>
</sec>
<sec><title>Genetic Manipulations</title>
<p>For the construction of a complementation plasmid a fragment comprising the <italic>ldh</italic> gene and its native promoter (280 bp upstream of the start codon) of the <italic>S. pyogenes</italic> M49 591 WT strain was amplified by PCR using a Phusion High Fidelity DNA polymerase. This fragment was inserted into the shuttle vector pAT19 (<xref ref-type="bibr" rid="B51">Trieu-Cuot et al., 1991</xref>) via <italic>Bam</italic>HI and <italic>Sal</italic>I restriction sites. Correct insertion of the fragment was confirmed by sequencing. The resulting plasmid was transferred into the <italic>S. pyogenes</italic> M49 591 <italic>ldh</italic> deletion strain via electroporation. The resulting strain <italic>S. pyogenes</italic> M49 591&#x0394;ldh::ldh was tested for LDH activity to confirm functional expression of the plasmid-located <italic>ldh</italic> gene.</p>
</sec>
<sec><title>Measurement of LDH Activity</title>
<p>For measurements of LDH activity, <italic>S. pyogenes</italic> strains were grown in THY under standard conditions. At mid-exponential growth phase (OD at 600 nm = 0.5) cells of 2 ml culture were pelleted by centrifugation and washed twice in sodium phosphate buffer (50 mM, pH 6.8). Intracellular proteins were released by enzymatic degradation of the cell wall with phage lysin PlyC for 10 min at 37&#x00B0;C as described previously (<xref ref-type="bibr" rid="B37">Nelson et al., 2006</xref>; <xref ref-type="bibr" rid="B23">Koller et al., 2008</xref>). Subsequently, lysates were centrifuged for 10 min at 20,000 <italic>g</italic> and 50 &#x03BC;l of the supernatants were applied in the activity assay either directly or in a 1:25 dilution in sodium phosphate buffer. LDH activity was determined via measurement of the conversion of NADH to NAD<sup>+</sup> as described previously (<xref ref-type="bibr" rid="B26">Levering et al., 2012</xref>). In brief, the reaction mixture contained 0.5 mM fructose-1,6-bisphosphate, 0.17 mM NADH, 10 mM sodium pyruvate and 50 &#x03BC;l sample in 50 mM sodium phosphate buffer (pH 6.8) in a total volume of 1 ml and the absorption at 340 nm was measured for 5 min. The specific activity is given in units per milligram protein, where 1 unit is defined as conversion of 1 &#x03BC;M NADH per minute. Protein concentrations in the <italic>S. pyogenes</italic> lysates were measured with the Pierce<sup>TM</sup> Coomassie (Bradford) Protein Assay Kit (Thermo Fisher Scientific).</p>
</sec>
<sec><title>Proteome Analysis by NanoLC-HDMS<sup>E</sup></title>
<p>In-solution digestion of proteins with trypsin in sodium deoxycholate-containing buffer was performed as previously described (<xref ref-type="bibr" rid="B32">Masuda et al., 2008</xref>; <xref ref-type="bibr" rid="B43">Pade et al., 2017</xref>) using total protein extracts prepared in a Precellys 24 homogenizer (peqLab Biotechnologie GmbH, Erlangen, Germany). Mass spectrometry was performed on a Synapt G2-S mass spectrometer (Waters, Manchester, United Kingdom) coupled to a nanoAcquity UPLC system (Waters) as described (<xref ref-type="bibr" rid="B43">Pade et al., 2017</xref>). In short, peptides mixtures were separated on an analytical column (ACQUITY UPLC HSS T3, 1.8 &#x03BC;m, 75 &#x03BC;m &#x00D7; 250 mm, Waters) at a flow rate of 300 nl/min using a gradient from 3 to 32% acetonitrile in 0.1% formic acid over 150 min. The SYNAPT G2-S instrument was operated in data-independent mode (<xref ref-type="bibr" rid="B17">Geromanos et al., 2009</xref>), characterized by parallel fragmentation of multiple precursor ions in combination with ion-mobility separation as an additional dimension of separation (referred to as HDMS<sup>E</sup>) (<xref ref-type="bibr" rid="B47">Shliaha et al., 2013</xref>; <xref ref-type="bibr" rid="B8">Distler et al., 2014</xref>). Samples were measured in duplicate.</p>
</sec>
<sec><title>NanoLC-HDMS<sup>E</sup> Data Processing, Protein Identification, and Quantification</title>
<p>Progenesis QI for Proteomics version 2.0 (Nonlinear Dynamics, Newcastle upon Tyne, United Kingdom) was used for raw data processing, protein identification, and label free quantification. For the database search a database containing 1701 protein sequences from <italic>S. pyogenes</italic> serotype M49 (strain NZ131) (UniProt release 2016_05) appended with the sequences of rabbit phosphorylase B (P00489) and porcine trypsin was compiled. One missing cleavage site was allowed, oxidation of methionine residues was considered as variable modification, and carbamidomethylation of cysteines as fixed modification. The false discovery rate based on the search of a reversed database was set to 1%. Peptides were required to be identified by at least three fragment ions and proteins by at least seven fragment ions and two peptides. With the subsequent filtering steps peptides were removed that had (i) a peptide score below 5.96, (ii) a mass error above 10 ppm, (iii) less than six amino acid residues. Proteins were quantified by the absolute quantification Hi3 method using Hi3 rabbit phosphorylase B Standard (Waters) as reference (<xref ref-type="bibr" rid="B48">Silva et al., 2006</xref>). Protein abundance changes by a factor of at least two, accompanied by ANOVA <italic>p</italic>-values &#x003C;0.05 for the comparison between the respective groups were regarded as significant.</p>
</sec>
<sec><title>Survival Assays</title>
<p>The survival assays in human blood or plasma were performed as described previously (<xref ref-type="bibr" rid="B36">Nakata et al., 2009</xref>). In short, bacteria grown in THY medium were harvested in the exponential growth phase (optical density at 600 nm of 0.4&#x2013;0.5). Bacteria were suspended in phosphate-buffered saline (PBS), the optical density at 600 nm was adjusted to 0.3 and this suspension was diluted 1:10,000 in PBS. The viable counts were determined by plating serial dilutions on THY agar plates. Twenty microliters of the bacterial suspension were inoculated into 480 &#x03BC;l of fresh citrated human blood or plasma and incubated for 3 h at 37&#x00B0;C with rotation. The viable counts were determined by plating serial dilutions on THY agar plates and related to the inoculum.</p>
</sec>
<sec><title>Ethics Approval Statement</title>
<p>The protocol for the collection of human blood for the blood and plasma survival assays was approved by the Ethikkommission an der Medizinischen Fakult&#x00E4;t der Universit&#x00E4;t Rostock (ethics committee vote: A 2014-0131). The experiments were conducted in accordance with the ICH-GCP guidelines. Informed consent was obtained from all subjects.</p>
</sec>
<sec><title>Western Blot Analysis</title>
<p>For sampling, overnight cultures were set to 2 &#x00D7; 10<sup>8</sup> CFU/ml and 250 &#x03BC;l were mixed with equal amount of human normal plasma and incubated at 37&#x00B0;C for 60 min with shaking (600 rpm). Incubation of plasma with PBS, bacteria with PBS and plasma with kaolin served as controls. Cells were pelleted by centrifugation, washed three times in PBS, suspended in 100 &#x03BC;l glycine (0.1 M) and incubated at room temperature for another 10 min. Cells were pelleted by centrifugation and supernatants were neutralized by the addition of 20 &#x03BC;l Tris&#x2013;HCl (1 M, pH 8.4). A total of 100 &#x03BC;l of the suspensions were mixed with 20 &#x03BC;l SDS sample buffer (5&#x00D7;). SDS-PAGE was performed as described earlier (<xref ref-type="bibr" rid="B39">Neville, 1971</xref>). Following SDS-PAGE, separated proteins were transferred onto nitrocellulose membranes. Western blot analyses were performed with sheep antibodies against HK (1:3,000; Affinity Biologicals) and its degradation products as described previously (<xref ref-type="bibr" rid="B33">Mattsson et al., 2001</xref>). Chemiluminescence was detected on a Kodak ID3.5 Image Station 440CF.</p>
</sec>
<sec><title>Dot Blot Analysis</title>
<p>For dot blot analysis, 100 &#x03BC;l of filter-sterilized (0.2 &#x03BC;m) supernatants (either pure or diluted with fresh THY) of overnight cultures of the bacteria in THY medium were transferred on a nitrocellulose membrane using a Bio-Dot<sup>&#x00AE;</sup> microfiltration apparatus (Bio-Rad). The detection was performed with a SpeB (bD-12) antibody from goat (1:1,000) and a donkey-anti-goat IgG-HRP secondary antibody (1:1,000; both Santa Cruz Biotechnology) as described elsewhere (<xref ref-type="bibr" rid="B33">Mattsson et al., 2001</xref>).</p>
</sec>
<sec><title>Measurement of FXII/PK Activity</title>
<p>FXII/PK activity on bacterial surfaces exposed to plasma was measured using chromogenic substrate S-2302 (H-D-Pro-Phe-Arg-pNA&#x22C5;2HCl; Chromogenix). Ten-milliliter overnight cultures (THB) of the <italic>S. pyogenes</italic> M49 strains were washed three times with 50 mM Tris&#x2013;HCl (pH 7.5) and diluted (final concentration, 3 &#x00D7; 10<sup>7</sup> CFU/ml) in 50 mM Tris buffer. Then, 100 &#x03BC;l of bacterial suspension was mixed with 100 &#x03BC;l of plasma or buffer (control), followed by incubation at 37&#x00B0;C for 30 min. After centrifugation, the pellets were washed three times and suspended in 200 &#x03BC;l of buffer containing 1 mM substrate S-2302. After 60 min at 37&#x00B0;C, the samples were centrifuged, and the absorbance of the supernatants was measured at 405 nm in a microplate reader. Control values (bacteria incubated in buffer) were used as a blank. No endogenous proteolytic activity was measured when S-2303 was incubated with bacteria in the absence of plasma.</p>
</sec>
<sec><title>Measurement of Plasmin Activity</title>
<p>To measure the plasmin activity on bacterial surfaces exposed to plasma, bacteria were grown overnight in 10 ml of THB, washed three times with PBS, and diluted (final concentration 5 &#x00D7; 10<sup>7</sup> CFU/ml) in PBS. Next, 200-&#x03BC;l bacterial suspensions were mixed with 200 &#x03BC;l of plasma or buffer, followed by incubation for 3 h. After three further washing steps with PBS, the pellet was suspended in Tris&#x2013;NaCl buffer (19.2 mM/1.062 M; pH 7.5) containing 20 &#x03BC;g/ml of the chromogenic substrate S-2251 (H-D-Val-Leu-Lys-pNA&#x22C5;2HCl; Sigma), followed by an incubation for 60 min at 37&#x00B0;C. Samples were centrifuged, and the absorbance of the supernatants was measured at 405 nm in a microplate reader.</p>
</sec>
<sec><title>Measurement of SpeB Activity</title>
<p>For determination of SpeB activity in bacterial culture supernatants bacteria were grown for 8 h in THY (Becton, Dickinson and Company), diluted 1:100 in fresh THY medium and further cultivated for 12 h. Cells were pelleted, 1 ml per supernatant was filter-sterilized (0.2 &#x03BC;m pore size), and 50 &#x03BC;l of sterile supernatants were activated with 2 mM dithiothreitol (DTT) for 30 min at 37&#x00B0;C. Then, 150 &#x03BC;l of substrate solution (1 mM N-benzoyl-Pro-Phe-Arg-p-NA, 60 mM sodium phosphate pH 6) were added and incubated for 2 h at 37&#x00B0;C. Absorbance was measured immediately after substrate addition and after the 2 h incubation at 405 nm in a microplate reader. As a specificity-control, samples without DTT activation and samples with addition of 0.05 mM cysteine protease inhibitor E64 (Sigma) were measured simultaneously.</p>
</sec>
<sec><title><italic>Galleria mellonella</italic> Infection Model</title>
<p>Larvae of the greater wax moth <italic>G. mellonella</italic> were obtained from Reptilienkosmos (Niederkr&#x00FC;chten, Germany). For infection experiments, <italic>S. pyogenes</italic> strains were grown overnight in THY, washed twice in a 0.75% NaCl solution and suspended in 0.75% NaCl to a final concentration of 1.5&#x2013;2 &#x00D7; 10<sup>8</sup> CFU/ml. Larvae with a weight of 150&#x2013;200 mg were inoculated with 10 &#x03BC;l of this bacterial suspension, resulting in an infection dose of 1.5&#x2013;2 &#x00D7; 10<sup>6</sup> CFU/larva. Bacteria were injected into the hemocoel of the larvae between the last pair of legs using a microapplicator (World Precisions Instruments, Sarasota, United States) and a fine dosage syringe (Omnican<sup>&#x00AE;</sup>-F, 0.01&#x2013;1 ml, 0.30 &#x00D7; 12 mm, B. Braun AG, Melsungen, Germany). As a control, larvae were mock inoculated with 10 &#x03BC;l of a 0.75% NaCl solution. Survival of the larvae was observed for seven days. Larvae were regarded dead when they were not moving upon repeated physical stimulation with tweezers (<xref ref-type="bibr" rid="B35">Mukherjee et al., 2010</xref>).</p>
</sec>
</sec>
<sec><title>Results</title>
<p>As previously reported, a deletion of the <italic>ldh</italic> gene in <italic>S. pyogenes</italic> M49 strain 591 leads to a metabolic switch from homofermentative lactate production to mixed acid fermentation but not to general growth retardation of the bacteria in laboratory media (<xref ref-type="bibr" rid="B12">Fiedler et al., 2011</xref>). Here we aimed to elucidate whether the loss of <sc>L</sc>-lactate dehydrogenase has an impact on the fitness of <italic>S. pyogenes</italic> in infection-related conditions. For that purpose we first constructed a complementation strain carrying a pAT19-based plasmid containing the <italic>S. pyogenes</italic> M49 strain 591 <italic>ldh</italic> gene with its native promoter. Protein extracts obtained from cells in the exponential growth phase (OD = 0.5) in THY medium showed the same specific LDH activity for complementation strain and WT, while extracts of the <italic>ldh</italic> deletion strain were completely devoid of L-LDH activity (<bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>). Furthermore, the abundance of proteins was analyzed in total extracts from exponentially growing bacteria of all three strains by label-free protein quantification using ion mobility-enhanced data-independent acquisition (HDMS<sup>E</sup>) (<xref ref-type="bibr" rid="B9">Distler et al., 2016</xref>). Protein extracts from three biological replicates per strain were pooled for these measurements. In the WT and complementation strain, pyruvate branching enzymes were at similar levels after overnight growth in THY, with relatively high abundance of lactate dehydrogenase and relatively low levels of pyruvate formate lyase and alcohol dehydrogenase as compared to the <italic>ldh</italic> deletion strain (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>). Abundance of glycolytic enzymes, i.e., phosphofructokinase, fructose-bisphosphate aldolase, glyceraldehyde-3-phosphate dehydrogenase, enolase, and pyruvate kinase, was similar in all three strains (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>). Hence, in terms of pyruvate branching, the complementation strain is able to restore the WT phenotype. The abundance of the enzymes encoded upstream and downstream of LDH (NADH oxidase and gyrase A) was unaffected in the <italic>ldh</italic> deletion strain (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>LDH-activity <bold>(A)</bold> and abundance of glycolytic and pyruvate branching enzymes <bold>(B)</bold>. LDH activity was measured in protein extracts of cultures grown to the exponential growth phase (OD<sub>600</sub> = 0.5) in THY (<italic>n</italic> = 3, <sup>&#x2217;</sup><italic>p</italic> &#x003C; 0.05, <sup>&#x2217;&#x2217;&#x2217;</sup><italic>p</italic> &#x003C; 0.001, unpaired two-tailed <italic>t</italic>-test). For the measurement of protein abundances <bold>(B)</bold>, protein extracts of three biological replicates of THY cultures (OD<sub>600</sub> = 0.5) were pooled and subjected to label-free protein quantification using nanoLC-HDMS<sup>E</sup>.</p></caption>
<graphic xlink:href="fmicb-08-01841-g001.tif"/>
</fig>
<p>Next, we assessed the ability of WT, <italic>ldh</italic> deletion mutant and complementation strains to multiply in citrated human blood and plasma, respectively. As shown in <bold>Figure <xref ref-type="fig" rid="F2">2A</xref></bold>, the <italic>ldh</italic> deletion strain had significantly lower multiplication rates in blood than WT and complementation strain. The phenotype in plasma resembled that in blood (<bold>Figure <xref ref-type="fig" rid="F2">2B</xref></bold>). This indicates that not only cellular components but also soluble components such as plasma proteins seem to be responsible for the reduced multiplication of the <italic>ldh</italic> deletion strain.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p>Growth in human blood <bold>(A)</bold> and plasma <bold>(B)</bold>. Bacteria were incubated in citrated blood or plasma for 3 h. Viable counts before and after the incubation were used to calculate multiplication rates (<italic>n</italic> &#x2265; 5, <sup>&#x2217;</sup><italic>p</italic> &#x003C; 0.05, <sup>&#x2217;&#x2217;</sup><italic>p</italic> &#x003C; 0.01, unpaired two-tailed <italic>t</italic>-test).</p></caption>
<graphic xlink:href="fmicb-08-01841-g002.tif"/>
</fig>
<p>Since the contact system is one of the humoral innate immune mechanisms that is activated by GAS M49 (<xref ref-type="bibr" rid="B41">Nitzsche et al., 2015</xref>), we analyzed the extent of contact activation at the surface of the bacteria. For that purpose the activity of the proteases FXII and PK bound to the bacterial surface after incubation in plasma was determined in a colorimetric assay. As depicted in <bold>Figure <xref ref-type="fig" rid="F3">3A</xref></bold>, the FXII/PK activity at the surface of the <italic>ldh</italic> deletion strain was significantly reduced compared to the WT. As contact system activation is accompanied with a degradation of HK, we analyzed whether intact HK is bound at the surface of M49, M49<sub>&#x0394;ldh</sub>, and M49<sub>&#x0394;ldh::ldh</sub> strains. For that purpose, bacteria were incubated in plasma, and, after washing, the adsorbed proteins were eluted from the surface and analyzed by western blot with antibodies directed against HK and low-molecular weight kininogen (LK). LK is a shorter splice variant of HK (<xref ref-type="bibr" rid="B15">Furuto-Kato et al., 1985</xref>), but has no function in contact activation (<xref ref-type="bibr" rid="B24">Lalmanach et al., 2010</xref>), and the polyclonal antiserum against HK also reacts with LK. Plasma alone or plasma treated with kaolin (a contact activator) served as negative and positive control, respectively. As depicted in <bold>Figure <xref ref-type="fig" rid="F3">3B</xref></bold>, in untreated plasma HK could be detected at 120 kDa and LK at 66 kDa. In the kaolin-treated plasma, HK was processed and consequently the signal at 120 kDa disappeared. A similar pattern was obtained in the eluate samples from the bacteria, which contain plasma proteins adsorbed at the surface of <italic>S. pyogenes</italic> and its mutants (<bold>Figure <xref ref-type="fig" rid="F3">3B</xref></bold>). The 120 kDa HK signal was completely absent in eluate samples from the WT and the complemented strain (<bold>Figure <xref ref-type="fig" rid="F3">3B</xref></bold>). This is in contrast to the <italic>ldh</italic> deletion strain, where intact 120 kDa HK was eluted from the bacterial surface (<bold>Figure <xref ref-type="fig" rid="F3">3B</xref></bold>). This implies that the <italic>ldh</italic> deletion strain does not degrade surface-bound HK, which is in line with its lower surface FXII/PK activity as described above (<bold>Figure <xref ref-type="fig" rid="F3">3A</xref></bold>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p>PK/FXII activity <bold>(A)</bold> and Western blot analysis of HK bound at the bacterial surface <bold>(B)</bold>. PK/FXII activity was determined in plasma samples exposed to the bacteria and depicted as rates of conversion of a chromogenic plasma kallikrein substrate (<italic>n</italic> = 3, <sup>&#x2217;</sup><italic>p</italic> &#x003C; 0.05, <sup>&#x2217;&#x2217;&#x2217;</sup><italic>p</italic> &#x003C; 0.001, unpaired two-tailed <italic>t</italic>-test). For Western blots, plasma proteins eluted for bacteria or kaolin (as a positive control) were applied to SDS-PAGE, blotted on nitrocellulose membranes, and detected with a kininogen-specific primary antibody and a HRP-conjugated secondary antibody.</p></caption>
<graphic xlink:href="fmicb-08-01841-g003.tif"/>
</fig>
<p>A major streptococcal protein interacting with the contact system is the secreted cysteine protease SpeB (<xref ref-type="bibr" rid="B38">Nelson et al., 2011</xref>) as it can degrade HK into kinins (<xref ref-type="bibr" rid="B18">Herwald et al., 1996</xref>). On the other hand SpeB also degrades bacterial virulence factors such as Ska and M protein (<xref ref-type="bibr" rid="B52">Walker et al., 2014</xref>). Therefore, we determined SpeB activity in the supernatants of THY cultures (<bold>Figure <xref ref-type="fig" rid="F4">4A</xref></bold>). In the supernatant of the <italic>ldh</italic> deletion strain no SpeB activity was detectable. In contrast, in the supernatants of WT and complementation strain significant SpeB activity was measured (<bold>Figure <xref ref-type="fig" rid="F4">4A</xref></bold>). Both&#x2014;PK and SpeB&#x2014;efficiently cleave HK (<xref ref-type="bibr" rid="B18">Herwald et al., 1996</xref>), thus the completely restored SpeB activity in the complemented strain probably induces the complete HK degradation, although FXII/PK levels are not fully restored in the complemented strain (<bold>Figure <xref ref-type="fig" rid="F3">3B</xref></bold>). In line with the absence of SpeB activity, the <italic>ldh</italic> deletion strain showed a significantly higher surface plasmin activity after incubation in human plasma compared to WT and complementation strain (<bold>Figure <xref ref-type="fig" rid="F4">4B</xref></bold>). The loss of SpeB activity in the <italic>ldh</italic> deletion strain is apparently not due to reduced SpeB production, as in dot blot analysis with SpeB-specific antibodies SpeB could be detected in the supernatants of all three strains (<bold>Figure <xref ref-type="fig" rid="F4">4C</xref></bold>). The reason for the absence of SpeB activity in the culture supernatants of the <italic>ldh</italic> deletion strain rather seems to be a disturbed autocatalytic activation of the 40 kDa SpeB zymogen into the 28 kDa mature SpeB. In the culture supernatant of the <italic>ldh</italic> deletion mutant there was only a faint signal for the mature 28 kDa SpeB detectable. Instead, intermediates frequently occurring in SpeB maturation accumulated (<xref ref-type="bibr" rid="B10">Doran et al., 1999</xref>; <xref ref-type="bibr" rid="B3">Chen et al., 2003</xref>) (<bold>Figure <xref ref-type="fig" rid="F4">4D</xref></bold>). In contrast, in supernatants of WT and complementation strain the mature SpeB was much more abundant than in the <italic>ldh</italic> deletion strain (<bold>Figure <xref ref-type="fig" rid="F4">4D</xref></bold>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>The <italic>ldh</italic> deletion has an impact on SpeB and plasmin activity. SpeB activity <bold>(A)</bold> was determined in culture supernatants of overnight cultures in THY (<italic>n</italic> = 4, <sup>&#x2217;&#x2217;&#x2217;&#x2217;</sup><italic>p</italic> &#x003C; 0.0001, unpaired two-tailed <italic>t</italic>-test), plasmin activity <bold>(B)</bold> was measured on the surface of bacteria after incubation in pooled human plasma (<italic>n</italic> = 3, <sup>&#x2217;&#x2217;&#x2217;</sup><italic>p</italic> &#x003C; 0.001, unpaired two-tailed <italic>t</italic>-test), dot blot analysis of SpeB abundance in culture supernatants with SpeB specific antibodies <bold>(C)</bold>, non-reducing SDS-PAGE showing SpeB activation via DTT treatment <bold>(D)</bold>.</p></caption>
<graphic xlink:href="fmicb-08-01841-g004.tif"/>
</fig>
<p>Sequencing of the <italic>speB</italic> locus in all three strains revealed no mutations in the promoter region or the coding sequence of the <italic>speB</italic> gene. In time-course experiments with exposure of the culture supernatants of all three strains to DTT for up to 7 h, we observed that in WT and complementation strain, the SpeB zymogen is almost completely converted into the mature SpeB after 1 h (<bold>Figure <xref ref-type="fig" rid="F5">5</xref></bold> and Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">1</xref>). In contrast, a visible accumulation of mature SpeB in the culture supernatants of the <italic>ldh</italic> deletion strain could only be observed after 3&#x2013;4 h incubation under reducing conditions (<bold>Figure <xref ref-type="fig" rid="F5">5</xref></bold> and Supplementary Figure <xref ref-type="supplementary-material" rid="SM2">1</xref>). The addition of 30 mM <sc>L</sc>-lactate to the culture supernatant of the mutant prior to the DTT activation did not lead to faster maturation of SpeB, indicating that missing lactate in the supernatants is not responsible for the delay in SpeB activation (see Supplementary Figure <xref ref-type="supplementary-material" rid="SM3">2</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>Impact of the <italic>ldh</italic> deletion on SpeB maturation. SpeB maturation in the culture supernatants of wild type, <italic>ldh</italic> deletion and complementation strain in the presence of DTT over 7 h was analyzed via SDS-PAGE.</p></caption>
<graphic xlink:href="fmicb-08-01841-g005.tif"/>
</fig>
<p>The streptococcal endopeptidase HtrA (aka DegP) has previously been reported to support the maturation of SpeB (<xref ref-type="bibr" rid="B31">Lyon and Caparon, 2004</xref>; <xref ref-type="bibr" rid="B46">Rosch and Caparon, 2005</xref>). Furthermore, cell-wall anchored M protein has been described to be necessary for maturation of SpeB in a M1 serotype GAS strain (<xref ref-type="bibr" rid="B5">Collin and Ols&#x00E9;n, 2000</xref>). In our proteomic data, we, however, found HtrA abundances unchanged in the <italic>ldh</italic> deletion strain compared to WT and complementation strain (see Supplementary Table <xref ref-type="supplementary-material" rid="SM1">1</xref>). The M protein amount in WT and <italic>ldh</italic> deletion strain was similar as well, while in the complementation strain a moderately increased M protein amount was measured (see Supplementary Table <xref ref-type="supplementary-material" rid="SM1">1</xref>).</p>
<p>To elucidate the impact of the <italic>ldh</italic> deletion on virulence of the M49 strain 591 <italic>in vivo</italic>, larvae of the greater wax moth <italic>G. mellonella</italic> were used as model organisms. <italic>G. mellonella</italic> is an easy-to-handle and well-established invertebrate infection model organism that reliably reflects differences in virulence of <italic>S. pyogenes</italic> as they can also be observed in more complex mammalian model organisms (<xref ref-type="bibr" rid="B42">Olsen et al., 2011</xref>; <xref ref-type="bibr" rid="B7">Cook and McArthur, 2013</xref>; <xref ref-type="bibr" rid="B27">Loh et al., 2013</xref>). Here, the larvae were inoculated with 1.5&#x2013;2 &#x00D7; 10<sup>6</sup> CFU/animal by injecting the bacterial suspension into the hemocoel of the larvae. As controls, larvae were mock-inoculated with an equal volume of a sterile physiological NaCl solution. Survival of the larvae was followed for 7 days after infection. Larvae infected with the <italic>ldh</italic> deletion mutant survived the 7-day period in a significantly higher proportion (54% living animals at day 7) than larvae infected with the WT (26%) or complementation strain (30%) (<bold>Figure <xref ref-type="fig" rid="F6">6</xref></bold>). Hence, the reduced virulence of the <italic>ldh</italic> deletion strain <italic>in vitro</italic> is also displayed <italic>in vivo</italic> in the <italic>Galleria</italic> infection model.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption><p><italic>Galleria mellonella</italic> infection model. Survival of <italic>G. mellonella</italic> larvae after infection with WT, <italic>ldh</italic> deletion and complementation strains (<italic>n</italic> = 50, <sup>&#x2217;&#x2217;</sup><italic>p</italic> &#x003C; 0.01, log-rank test).</p></caption>
<graphic xlink:href="fmicb-08-01841-g006.tif"/>
</fig>
</sec>
<sec><title>Discussion</title>
<p>The secreted streptococcal cysteine protease SpeB is one of the central virulence factors of GAS. SpeB is associated with an invasive phenotype of the bacteria (<xref ref-type="bibr" rid="B2">Carroll and Musser, 2011</xref>). SpeB degrades host proteins as well as proteins secreted by GAS (<xref ref-type="bibr" rid="B38">Nelson et al., 2011</xref>). After biosynthesis, cytosolic SpeB is probably kept inactive by the SpeB inhibitor protein Spi, which is encoded on a bicistronic operon with the <italic>speB</italic> gene (<xref ref-type="bibr" rid="B20">Kagawa et al., 2005</xref>). During secretion of SpeB via the ExPortal protein secretion microdomain located Sec translocon of <italic>S. pyogenes</italic> (<xref ref-type="bibr" rid="B45">Rosch and Caparon, 2004</xref>, <xref ref-type="bibr" rid="B46">2005</xref>), the leader peptide is cleaved off, and the protein is released into the extracellular space as a 40 kDa zymogen (<xref ref-type="bibr" rid="B10">Doran et al., 1999</xref>). The SpeB zymogen can either be autocatalytically cleaved into the mature enzyme or be cleaved by the mature enzyme itself. Over the maturation process, up to eight intermediate forms of SpeB can be found (<xref ref-type="bibr" rid="B10">Doran et al., 1999</xref>; <xref ref-type="bibr" rid="B3">Chen et al., 2003</xref>).</p>
<p>Here, we show that in an <italic>ldh</italic> deletion strain of <italic>S. pyogenes</italic> M49 strain 591, the activation of the SpeB zymogen into the mature active SpeB enzyme is hampered. Full virulence and a complete regain of SpeB activity is achieved by extrachromosomal expression of the <italic>ldh</italic> gene in the <italic>ldh</italic> deletion background. The missing SpeB activity likely contributes to the reduced virulence of the M49 <italic>ldh</italic> deletion strain. In accordance with our findings, it has previously been shown that SpeB promotes survival of <italic>S. pyogenes</italic> in human blood (<xref ref-type="bibr" rid="B50">Terao et al., 2008</xref>) and that the absence of SpeB renders <italic>S. pyogenes</italic> more prone to phagocytosis by neutrophils (<xref ref-type="bibr" rid="B28">Lukomski et al., 1998</xref>). In accordance with that, GAS M49 mutants lacking active SpeB have a decreased virulence in murine intraperitoneal and skin infection models (<xref ref-type="bibr" rid="B30">Lukomski et al., 1997</xref>, <xref ref-type="bibr" rid="B28">1998</xref>, <xref ref-type="bibr" rid="B29">1999</xref>; <xref ref-type="bibr" rid="B34">Meinert Niclasen et al., 2011</xref>).</p>
<p>Next to the impact on susceptibility toward phagocytosis, another virulence mechanism associated with SpeB is the ability to cleave HK, with the release of pro-inflammatory kinins, independent from PK activation (<xref ref-type="bibr" rid="B18">Herwald et al., 1996</xref>). The data of the present study show that upon <italic>ldh</italic> deletion the bacteria have a reduced PK/FXII activity and reduced HK cleavage on their surface. Both&#x2014;PK and SpeB&#x2014;efficiently cleave HK, resulting in release of BK, which leads to increased vascular permeability promoting spread of the infection and providing nutrients to growing bacteria (<xref ref-type="bibr" rid="B1">Ben Nasr et al., 1997</xref>). Thus reduced PK/FXII activity in combination with the lack of SpeB activity reduces HK cleavage and may further contribute to a reduced virulence.</p>
<p>In addition to the decreased virulence due to the loss of SpeB activity, the missing ability of lactate fermentation might represent a metabolic disadvantage in blood or the larvae. For <italic>Streptococcus pneumoniae</italic> an <italic>ldh</italic> deletion strain has been described to be avirulent in an intravenous mouse infection model (<xref ref-type="bibr" rid="B16">Gaspar et al., 2014</xref>). The authors attribute the loss in virulence to a decreased fitness of the <italic>S. pneumoniae ldh</italic> deletion strain, since the bacteria are forced to use the inefficient mixed acid branch of pyruvate metabolism in the absence of lactate dehydrogenase. This is also reflected by a general growth deficiency of the <italic>S. pneumoniae ldh</italic> deletion strain in laboratory media (<xref ref-type="bibr" rid="B16">Gaspar et al., 2014</xref>). In <italic>S. pyogenes</italic> the <italic>ldh</italic> deletion also leads to a shift from homofermentative lactate production to mixed acid fermentation (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>) (<xref ref-type="bibr" rid="B12">Fiedler et al., 2011</xref>). The <italic>ldh</italic> deletion, however, had only marginal effects on growth efficiency in laboratory media, a finding that also holds for other homofermentative lactic acid bacteria, i.e., <italic>Enterococcus faecalis</italic> and <italic>Lactococcus lactis</italic> (<xref ref-type="bibr" rid="B12">Fiedler et al., 2011</xref>). Therefore, a general growth deficiency of the <italic>S. pyogenes ldh</italic> deletion strain cannot be held responsible for the loss in virulence of this strain. Anyway, it still cannot be excluded that the <italic>ldh</italic> deletion represents a disadvantage in terms of metabolic fitness in infection relevant conditions.</p>
<p>The main question remaining is how the <italic>ldh</italic> deletion interferes with SpeB maturation. Hampered SpeB activation has also been reported by <xref ref-type="bibr" rid="B4">Cho and Kang (2013)</xref> for a c-di-AMP phosphodiesterase mutant of <italic>S. pyogenes</italic> HSC5, a M14 strain. As in the study of <xref ref-type="bibr" rid="B4">Cho and Kang (2013)</xref>, the underlying mechanism of interference with SpeB maturation remains obscure and needs further investigation.</p>
</sec>
<sec><title>Author Contributions</title>
<p>SO-H, BK, and TF planned the experiments. SM, JW, and LN did the experiments. SO-H, TF, and SM analyzed the data. TF wrote the manuscript. SO-H, SM, and BK edited the manuscript.</p>
</sec>
<sec><title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was funded by the German Federal Ministry of Education and Research (BMBF) in the framework of the SysMO-Systems Biology of Microorganisms initiative.</p>
</fn>
</fn-group>
<ack>
<p>We thank Jana Normann and Yvonne Humboldt for expert technical assistance and Dr. Nadja Patenge for her help with the <italic>Galleria mellonella</italic> infection model.</p>
</ack>
<sec sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fmicb.2017.01841/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fmicb.2017.01841/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.PDF" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
</supplementary-material>
<supplementary-material xlink:href="Image_1.PDF" id="SM2" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
</supplementary-material>
<supplementary-material xlink:href="Image_2.PDF" id="SM3" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink">
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ben Nasr</surname> <given-names>A.</given-names></name> <name><surname>Herwald</surname> <given-names>H.</given-names></name> <name><surname>Sjobring</surname> <given-names>U.</given-names></name> <name><surname>Renne</surname> <given-names>T.</given-names></name> <name><surname>Muller-Esterl</surname> <given-names>W.</given-names></name> <name><surname>Bjorck</surname> <given-names>L.</given-names></name></person-group> (<year>1997</year>). <article-title>Absorption of kininogen from human plasma by <italic>Streptococcus pyogenes</italic> is followed by the release of bradykinin.</article-title> <source><italic>Biochem. J.</italic></source> <volume>326(Pt 3)</volume>, <fpage>657</fpage>&#x2013;<lpage>660</lpage>.</citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname> <given-names>R. K.</given-names></name> <name><surname>Musser</surname> <given-names>J. M.</given-names></name></person-group> (<year>2011</year>). <article-title>From transcription to activation: how group A streptococcus, the flesh-eating pathogen, regulates SpeB cysteine protease production.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>81</volume> <fpage>588</fpage>&#x2013;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2011.07709.x</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>C. Y.</given-names></name> <name><surname>Luo</surname> <given-names>S. C.</given-names></name> <name><surname>Kuo</surname> <given-names>C. F.</given-names></name> <name><surname>Lin</surname> <given-names>Y. S.</given-names></name> <name><surname>Wu</surname> <given-names>J. J.</given-names></name> <name><surname>Lin</surname> <given-names>M. T.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Maturation processing and characterization of streptopain.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>278</volume> <fpage>17336</fpage>&#x2013;<lpage>17343</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M209038200</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname> <given-names>K. H.</given-names></name> <name><surname>Kang</surname> <given-names>S. O.</given-names></name></person-group> (<year>2013</year>). <article-title><italic>Streptococcus pyogenes</italic> c-di-AMP phosphodiesterase, GdpP, influences SpeB processing and virulence.</article-title> <source><italic>PLOS ONE</italic></source> <volume>8</volume>: <issue>e69425</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0069425</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collin</surname> <given-names>M.</given-names></name> <name><surname>Ols&#x00E9;n</surname> <given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>36</volume> <fpage>1306</fpage>&#x2013;<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2000.01942.x</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collin</surname> <given-names>M.</given-names></name> <name><surname>Ols&#x00E9;n</surname> <given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>Effect of SpeB and EndoS from <italic>Streptococcus pyogenes</italic> on human immunoglobulins.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>69</volume> <fpage>7187</fpage>&#x2013;<lpage>7189</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.69.11.7187-7189.2001</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname> <given-names>S. M.</given-names></name> <name><surname>McArthur</surname> <given-names>J. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Developing <italic>Galleria mellonella</italic> as a model host for human pathogens.</article-title> <source><italic>Virulence</italic></source> <volume>4</volume> <fpage>350</fpage>&#x2013;<lpage>353</lpage>. <pub-id pub-id-type="doi">10.4161/viru.25240</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Distler</surname> <given-names>U.</given-names></name> <name><surname>Kuharev</surname> <given-names>J.</given-names></name> <name><surname>Navarro</surname> <given-names>P.</given-names></name> <name><surname>Levin</surname> <given-names>Y.</given-names></name> <name><surname>Schild</surname> <given-names>H.</given-names></name> <name><surname>Tenzer</surname> <given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics.</article-title> <source><italic>Nat. Methods</italic></source> <volume>11</volume> <fpage>167</fpage>&#x2013;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2767</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Distler</surname> <given-names>U.</given-names></name> <name><surname>Kuharev</surname> <given-names>J.</given-names></name> <name><surname>Navarro</surname> <given-names>P.</given-names></name> <name><surname>Tenzer</surname> <given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Label-free quantification in ion mobility-enhanced data-independent acquisition proteomics.</article-title> <source><italic>Nat. Protoc.</italic></source> <volume>11</volume> <fpage>795</fpage>&#x2013;<lpage>812</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2016.042</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doran</surname> <given-names>J. D.</given-names></name> <name><surname>Nomizu</surname> <given-names>M.</given-names></name> <name><surname>Takebe</surname> <given-names>S.</given-names></name> <name><surname>M&#x00E9;nard</surname> <given-names>R.</given-names></name> <name><surname>Griffith</surname> <given-names>D.</given-names></name> <name><surname>Ziomek</surname> <given-names>E.</given-names></name></person-group> (<year>1999</year>). <article-title>Autocatalytic processing of the streptococcal cysteine protease zymogen.</article-title> <source><italic>Eur. J. Biochem.</italic></source> <volume>263</volume> <fpage>145</fpage>&#x2013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1046/j.1432-1327.1999.00473.x</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feldman-Salit</surname> <given-names>A.</given-names></name> <name><surname>Hering</surname> <given-names>S.</given-names></name> <name><surname>Messiha</surname> <given-names>H. L.</given-names></name> <name><surname>Veith</surname> <given-names>N.</given-names></name> <name><surname>Cojocaru</surname> <given-names>V.</given-names></name> <name><surname>Sieg</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Regulation of the activity of lactate dehydrogenases from four lactic Acid bacteria.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>288</volume> <fpage>21295</fpage>&#x2013;<lpage>21306</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.458265</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiedler</surname> <given-names>T.</given-names></name> <name><surname>Bekker</surname> <given-names>M.</given-names></name> <name><surname>Jonsson</surname> <given-names>M.</given-names></name> <name><surname>Mehmeti</surname> <given-names>I.</given-names></name> <name><surname>Pritzschke</surname> <given-names>A.</given-names></name> <name><surname>Siemens</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Characterization of three lactic acid bacteria and their isogenic ldh deletion mutants shows optimization for YATP (cell mass produced per mole of ATP) at their physiological pHs.</article-title> <source><italic>Appl. Environ. Microbiol.</italic></source> <volume>77</volume> <fpage>612</fpage>&#x2013;<lpage>617</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01838-10</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiedler</surname> <given-names>T.</given-names></name> <name><surname>Sugareva</surname> <given-names>V.</given-names></name> <name><surname>Patenge</surname> <given-names>N.</given-names></name> <name><surname>Kreikemeyer</surname> <given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title>Insights into <italic>Streptococcus pyogenes</italic> pathogenesis from transcriptome studies.</article-title> <source><italic>Future Microbiol.</italic></source> <volume>5</volume> <fpage>1675</fpage>&#x2013;<lpage>1694</lpage>. <pub-id pub-id-type="doi">10.2217/fmb.10.128</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frick</surname> <given-names>I. M.</given-names></name> <name><surname>Akesson</surname> <given-names>P.</given-names></name> <name><surname>Herwald</surname> <given-names>H.</given-names></name> <name><surname>Morgelin</surname> <given-names>M.</given-names></name> <name><surname>Malmsten</surname> <given-names>M.</given-names></name> <name><surname>Nagler</surname> <given-names>D. K.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>The contact system&#x2013;a novel branch of innate immunity generating antibacterial peptides.</article-title> <source><italic>EMBO J.</italic></source> <volume>25</volume> <fpage>5569</fpage>&#x2013;<lpage>5578</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601422</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furuto-Kato</surname> <given-names>S.</given-names></name> <name><surname>Matsumoto</surname> <given-names>A.</given-names></name> <name><surname>Kitamura</surname> <given-names>N.</given-names></name> <name><surname>Nakanishi</surname> <given-names>S.</given-names></name></person-group> (<year>1985</year>). <article-title>Primary structures of the mRNAs encoding the rat precursors for bradykinin and T-kinin. Structural relationship of kininogens with major acute phase protein and alpha 1-cysteine proteinase inhibitor.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>260</volume> <fpage>12054</fpage>&#x2013;<lpage>12059</lpage>.</citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaspar</surname> <given-names>P.</given-names></name> <name><surname>Al-Bayati</surname> <given-names>F. A.</given-names></name> <name><surname>Andrew</surname> <given-names>P. W.</given-names></name> <name><surname>Neves</surname> <given-names>A. R.</given-names></name> <name><surname>Yesilkaya</surname> <given-names>H.</given-names></name></person-group> (<year>2014</year>). <article-title>Lactate dehydrogenase is the key enzyme for pneumococcal pyruvate metabolism and pneumococcal survival in blood.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>82</volume> <fpage>5099</fpage>&#x2013;<lpage>5109</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.02005-14</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geromanos</surname> <given-names>S. J.</given-names></name> <name><surname>Vissers</surname> <given-names>J. P.</given-names></name> <name><surname>Silva</surname> <given-names>J. C.</given-names></name> <name><surname>Dorschel</surname> <given-names>C. A.</given-names></name> <name><surname>Li</surname> <given-names>G. Z.</given-names></name> <name><surname>Gorenstein</surname> <given-names>M. V.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS.</article-title> <source><italic>Proteomics</italic></source> <volume>9</volume> <fpage>1683</fpage>&#x2013;<lpage>1695</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.200800562</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herwald</surname> <given-names>H.</given-names></name> <name><surname>Collin</surname> <given-names>M.</given-names></name> <name><surname>M&#x00FC;ller-Esterl</surname> <given-names>W.</given-names></name> <name><surname>Bj&#x00F6;rck</surname> <given-names>L.</given-names></name></person-group> (<year>1996</year>). <article-title>Streptococcal cysteine proteinase releases kinins: a virulence mechanism.</article-title> <source><italic>J. Exp. Med.</italic></source> <volume>184</volume> <fpage>665</fpage>&#x2013;<lpage>673</lpage>. <pub-id pub-id-type="doi">10.1084/jem.184.2.665</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Honda-Ogawa</surname> <given-names>M.</given-names></name> <name><surname>Ogawa</surname> <given-names>T.</given-names></name> <name><surname>Terao</surname> <given-names>Y.</given-names></name> <name><surname>Sumitomo</surname> <given-names>T.</given-names></name> <name><surname>Nakata</surname> <given-names>M.</given-names></name> <name><surname>Ikebe</surname> <given-names>K.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Cysteine proteinase from <italic>Streptococcus pyogenes</italic> enables evasion of innate immunity via degradation of complement factors.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>288</volume> <fpage>15854</fpage>&#x2013;<lpage>15864</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.469106</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kagawa</surname> <given-names>T. F.</given-names></name> <name><surname>O&#x2019;Toole</surname> <given-names>P. W.</given-names></name> <name><surname>Cooney</surname> <given-names>J. C.</given-names></name></person-group> (<year>2005</year>). <article-title>SpeB - Spi: a novel protease - inhibitor pair from <italic>Streptococcus pyogenes</italic>.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>57</volume> <fpage>650</fpage>&#x2013;<lpage>666</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04708.x</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kapur</surname> <given-names>V.</given-names></name> <name><surname>Majesky</surname> <given-names>M. W.</given-names></name> <name><surname>Li</surname> <given-names>L. L.</given-names></name> <name><surname>Black</surname> <given-names>R. A.</given-names></name> <name><surname>Musser</surname> <given-names>J. M.</given-names></name></person-group> (<year>1993a</year>). <article-title>Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from <italic>Streptococcus pyogenes</italic>.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>90</volume> <fpage>7676</fpage>&#x2013;<lpage>7680</lpage>.</citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kapur</surname> <given-names>V.</given-names></name> <name><surname>Topouzis</surname> <given-names>S.</given-names></name> <name><surname>Majesky</surname> <given-names>M. W.</given-names></name> <name><surname>Li</surname> <given-names>L. L.</given-names></name> <name><surname>Hamrick</surname> <given-names>M. R.</given-names></name> <name><surname>Hamill</surname> <given-names>R. J.</given-names></name><etal/></person-group> (<year>1993b</year>). <article-title>A conserved <italic>Streptococcus pyogenes</italic> extracellular cysteine protease cleaves human fibronectin and degrades vitronectin.</article-title> <source><italic>Microb. Pathog.</italic></source> <volume>15</volume> <fpage>327</fpage>&#x2013;<lpage>346</lpage>.</citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koller</surname> <given-names>T.</given-names></name> <name><surname>Nelson</surname> <given-names>D.</given-names></name> <name><surname>Nakata</surname> <given-names>M.</given-names></name> <name><surname>Kreutzer</surname> <given-names>M.</given-names></name> <name><surname>Fischetti</surname> <given-names>V. A.</given-names></name> <name><surname>Glocker</surname> <given-names>M. O.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>PlyC, a novel bacteriophage lysin for compartment-dependent proteomics of group A streptococci.</article-title> <source><italic>Proteomics</italic></source> <volume>8</volume> <fpage>140</fpage>&#x2013;<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.200700001</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lalmanach</surname> <given-names>G.</given-names></name> <name><surname>Naudin</surname> <given-names>C.</given-names></name> <name><surname>Lecaille</surname> <given-names>F.</given-names></name> <name><surname>Fritz</surname> <given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Kininogens: more than cysteine protease inhibitors and kinin precursors.</article-title> <source><italic>Biochimie</italic></source> <volume>92</volume> <fpage>1568</fpage>&#x2013;<lpage>1579</lpage>. <pub-id pub-id-type="doi">10.1016/j.biochi.2010.03.011</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levering</surname> <given-names>J.</given-names></name> <name><surname>Fiedler</surname> <given-names>T.</given-names></name> <name><surname>Sieg</surname> <given-names>A.</given-names></name> <name><surname>van Grinsven</surname> <given-names>K. W. A.</given-names></name> <name><surname>Hering</surname> <given-names>S.</given-names></name> <name><surname>Veith</surname> <given-names>N.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Genome-scale reconstruction of the <italic>Streptococcus pyogenes</italic> M49 metabolic network reveals growth requirements and indicates potential drug targets.</article-title> <source><italic>J. Biotechnol.</italic></source> <volume>232</volume> <fpage>25</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2016.01.035</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levering</surname> <given-names>J.</given-names></name> <name><surname>Musters</surname> <given-names>M. W.</given-names></name> <name><surname>Bekker</surname> <given-names>M.</given-names></name> <name><surname>Bellomo</surname> <given-names>D.</given-names></name> <name><surname>Fiedler</surname> <given-names>T.</given-names></name> <name><surname>de Vos</surname> <given-names>W. M.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Role of phosphate in the central metabolism of two lactic acid bacteria&#x2013;a comparative systems biology approach.</article-title> <source><italic>FEBS J.</italic></source> <volume>279</volume> <fpage>1274</fpage>&#x2013;<lpage>1290</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2012.08523.x</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname> <given-names>J. M.</given-names></name> <name><surname>Adenwalla</surname> <given-names>N.</given-names></name> <name><surname>Wiles</surname> <given-names>S.</given-names></name> <name><surname>Proft</surname> <given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title><italic>Galleria mellonella</italic> larvae as an infection model for group A streptococcus.</article-title> <source><italic>Virulence</italic></source> <volume>4</volume> <fpage>419</fpage>&#x2013;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.4161/viru.24930</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lukomski</surname> <given-names>S.</given-names></name> <name><surname>Burns</surname> <given-names>E. H.</given-names> <suffix>Jr.</suffix></name> <name><surname>Wyde</surname> <given-names>P. R.</given-names></name> <name><surname>Podbielski</surname> <given-names>A.</given-names></name> <name><surname>Rurangirwa</surname> <given-names>J.</given-names></name> <name><surname>Moore-Poveda</surname> <given-names>D. K.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by <italic>Streptococcus pyogenes</italic> decreases resistance to phagocytosis and dissemination to organs.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>66</volume> <fpage>771</fpage>&#x2013;<lpage>776</lpage>.</citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lukomski</surname> <given-names>S.</given-names></name> <name><surname>Montgomery</surname> <given-names>C. A.</given-names></name> <name><surname>Rurangirwa</surname> <given-names>J.</given-names></name> <name><surname>Geske</surname> <given-names>R. S.</given-names></name> <name><surname>Barrish</surname> <given-names>J. P.</given-names></name> <name><surname>Adams</surname> <given-names>G. J.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Extracellular cysteine protease produced by <italic>Streptococcus pyogenes</italic> participates in the pathogenesis of invasive skin infection and dissemination in mice.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>67</volume> <fpage>1779</fpage>&#x2013;<lpage>1788</lpage>.</citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lukomski</surname> <given-names>S.</given-names></name> <name><surname>Sreevatsan</surname> <given-names>S.</given-names></name> <name><surname>Amberg</surname> <given-names>C.</given-names></name> <name><surname>Reichardt</surname> <given-names>W.</given-names></name> <name><surname>Woischnik</surname> <given-names>M.</given-names></name> <name><surname>Podbielski</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>1997</year>). <article-title>Inactivation of <italic>Streptococcus pyogenes</italic> extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains.</article-title> <source><italic>J. Clin. Invest.</italic></source> <volume>99</volume> <fpage>2574</fpage>&#x2013;<lpage>2580</lpage>. <pub-id pub-id-type="doi">10.1172/JCI119445</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname> <given-names>W. R.</given-names></name> <name><surname>Caparon</surname> <given-names>M. G.</given-names></name></person-group> (<year>2004</year>). <article-title>Role for serine protease HtrA (DegP) of <italic>Streptococcus pyogenes</italic> in the biogenesis of virulence factors SpeB and the hemolysin streptolysin S.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>72</volume> <fpage>1618</fpage>&#x2013;<lpage>1625</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.72.3.1618-1625.2004</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Masuda</surname> <given-names>T.</given-names></name> <name><surname>Tomita</surname> <given-names>M.</given-names></name> <name><surname>Ishihama</surname> <given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis.</article-title> <source><italic>J. Proteome Res.</italic></source> <volume>7</volume> <fpage>731</fpage>&#x2013;<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1021/pr700658q</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattsson</surname> <given-names>E.</given-names></name> <name><surname>Herwald</surname> <given-names>H.</given-names></name> <name><surname>Cramer</surname> <given-names>H.</given-names></name> <name><surname>Persson</surname> <given-names>K.</given-names></name> <name><surname>Sjobring</surname> <given-names>U.</given-names></name> <name><surname>Bjorck</surname> <given-names>L.</given-names></name></person-group> (<year>2001</year>). <article-title>Staphylococcus aureus induces release of bradykinin in human plasma.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>69</volume> <fpage>3877</fpage>&#x2013;<lpage>3882</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.69.6.3877-3882.2001</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meinert Niclasen</surname> <given-names>L.</given-names></name> <name><surname>Olsen</surname> <given-names>J. G.</given-names></name> <name><surname>Dagil</surname> <given-names>R.</given-names></name> <name><surname>Qing</surname> <given-names>Z.</given-names></name> <name><surname>Sorensen</surname> <given-names>O. E.</given-names></name> <name><surname>Kragelund</surname> <given-names>B. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Streptococcal pyogenic exotoxin B (SpeB) boosts the contact system via binding of alpha-1 antitrypsin.</article-title> <source><italic>Biochem. J.</italic></source> <volume>434</volume> <fpage>123</fpage>&#x2013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20100984</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname> <given-names>K.</given-names></name> <name><surname>Altincicek</surname> <given-names>B.</given-names></name> <name><surname>Hain</surname> <given-names>T.</given-names></name> <name><surname>Domann</surname> <given-names>E.</given-names></name> <name><surname>Vilcinskas</surname> <given-names>A.</given-names></name> <name><surname>Chakraborty</surname> <given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title><italic>Galleria mellonella</italic> as a model system for studying <italic>Listeria</italic> pathogenesis.</article-title> <source><italic>Appl. Environ. Microbiol.</italic></source> <volume>76</volume> <fpage>310</fpage>&#x2013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01301-09</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakata</surname> <given-names>M.</given-names></name> <name><surname>Koller</surname> <given-names>T.</given-names></name> <name><surname>Moritz</surname> <given-names>K.</given-names></name> <name><surname>Ribardo</surname> <given-names>D.</given-names></name> <name><surname>Jonas</surname> <given-names>L.</given-names></name> <name><surname>McIver</surname> <given-names>K. S.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Mode of expression and functional characterization of FCT-3 pilus region-encoded proteins in <italic>Streptococcus pyogenes</italic> serotype M49.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>77</volume> <fpage>32</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00772-08</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>D.</given-names></name> <name><surname>Schuch</surname> <given-names>R.</given-names></name> <name><surname>Chahales</surname> <given-names>P.</given-names></name> <name><surname>Zhu</surname> <given-names>S.</given-names></name> <name><surname>Fischetti</surname> <given-names>V. A.</given-names></name></person-group> (<year>2006</year>). <article-title>PlyC: a multimeric bacteriophage lysin.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>103</volume> <fpage>10765</fpage>&#x2013;<lpage>10770</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0604521103</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>D. C.</given-names></name> <name><surname>Garbe</surname> <given-names>J.</given-names></name> <name><surname>Collin</surname> <given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Cysteine proteinase SpeB from <italic>Streptococcus pyogenes</italic> - a potent modifier of immunologically important host and bacterial proteins.</article-title> <source><italic>Biol. Chem.</italic></source> <volume>392</volume> <fpage>1077</fpage>&#x2013;<lpage>1088</lpage>. <pub-id pub-id-type="doi">10.1515/BC.2011.208</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neville</surname> <given-names>D. M.</given-names> <suffix>Jr.</suffix></name></person-group> (<year>1971</year>). <article-title>Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>246</volume> <fpage>6328</fpage>&#x2013;<lpage>6334</lpage>.</citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nickel</surname> <given-names>K. F.</given-names></name> <name><surname>Renne</surname> <given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Crosstalk of the plasma contact system with bacteria.</article-title> <source><italic>Thromb. Res.</italic></source> <volume>130(Suppl. 1)</volume>, <fpage>S78</fpage>&#x2013;<lpage>S83</lpage>. <pub-id pub-id-type="doi">10.1016/j.thromres.2012.08.284</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nitzsche</surname> <given-names>R.</given-names></name> <name><surname>Rosenheinrich</surname> <given-names>M.</given-names></name> <name><surname>Kreikemeyer</surname> <given-names>B.</given-names></name> <name><surname>Oehmcke-Hecht</surname> <given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title><italic>Streptococcus pyogenes</italic> triggers activation of the human contact system by streptokinase.</article-title> <source><italic>Infect. Immun.</italic></source> <volume>83</volume> <fpage>3035</fpage>&#x2013;<lpage>3042</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00180-15</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname> <given-names>R. J.</given-names></name> <name><surname>Watkins</surname> <given-names>M. E.</given-names></name> <name><surname>Cantu</surname> <given-names>C. C.</given-names></name> <name><surname>Beres</surname> <given-names>S. B.</given-names></name> <name><surname>Musser</surname> <given-names>J. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Virulence of serotype M3 Group A Streptococcus strains in wax worms (<italic>Galleria mellonella</italic> larvae).</article-title> <source><italic>Virulence</italic></source> <volume>2</volume> <fpage>111</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.4161/viru.2.2.14338</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pade</surname> <given-names>N.</given-names></name> <name><surname>Mikkat</surname> <given-names>S.</given-names></name> <name><surname>Hagemann</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Ethanol, glycogen and glucosylglycerol represent competing carbon pools in ethanol-producing cells of <italic>Synechocystis</italic> sp. PCC 6803 under high-salt conditions.</article-title> <source><italic>Microbiology</italic></source> <volume>163</volume> <fpage>300</fpage>&#x2013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.000433</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patenge</surname> <given-names>N.</given-names></name> <name><surname>Fiedler</surname> <given-names>T.</given-names></name> <name><surname>Kreikemeyer</surname> <given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Common regulators of virulence in streptococci.</article-title> <source><italic>Curr. Top. Microbiol. Immunol.</italic></source> <volume>368</volume> <fpage>111</fpage>&#x2013;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1007/82_2012_295</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosch</surname> <given-names>J.</given-names></name> <name><surname>Caparon</surname> <given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>A microdomain for protein secretion in Gram-positive bacteria.</article-title> <source><italic>Science</italic></source> <volume>304</volume> <fpage>1513</fpage>&#x2013;<lpage>1515</lpage>. <pub-id pub-id-type="doi">10.1126/science.1097404</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosch</surname> <given-names>J. W.</given-names></name> <name><surname>Caparon</surname> <given-names>M. G.</given-names></name></person-group> (<year>2005</year>). <article-title>The ExPortal: an organelle dedicated to the biogenesis of secreted proteins in <italic>Streptococcus pyogenes</italic>.</article-title> <source><italic>Mol. Microbiol.</italic></source> <volume>58</volume> <fpage>959</fpage>&#x2013;<lpage>968</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04887.x</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shliaha</surname> <given-names>P. V.</given-names></name> <name><surname>Bond</surname> <given-names>N. J.</given-names></name> <name><surname>Gatto</surname> <given-names>L.</given-names></name> <name><surname>Lilley</surname> <given-names>K. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Effects of traveling wave ion mobility separation on data independent acquisition in proteomics studies.</article-title> <source><italic>J. Proteome Res.</italic></source> <volume>12</volume> <fpage>2323</fpage>&#x2013;<lpage>2339</lpage>. <pub-id pub-id-type="doi">10.1021/pr300775k</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname> <given-names>J. C.</given-names></name> <name><surname>Gorenstein</surname> <given-names>M. V.</given-names></name> <name><surname>Li</surname> <given-names>G. Z.</given-names></name> <name><surname>Vissers</surname> <given-names>J. P.</given-names></name> <name><surname>Geromanos</surname> <given-names>S. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition.</article-title> <source><italic>Mol. Cell. Proteomics</italic></source> <volume>5</volume> <fpage>144</fpage>&#x2013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M500230-MCP200</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Svensson</surname> <given-names>M. D.</given-names></name> <name><surname>Sj&#x00F6;bring</surname> <given-names>U.</given-names></name> <name><surname>Luo</surname> <given-names>F.</given-names></name> <name><surname>Bessen</surname> <given-names>D. E.</given-names></name></person-group> (<year>2002</year>). <article-title>Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo.</article-title> <source><italic>Microbiology</italic></source> <volume>148</volume> <fpage>3933</fpage>&#x2013;<lpage>3945</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-148-12-3933</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Terao</surname> <given-names>Y.</given-names></name> <name><surname>Mori</surname> <given-names>Y.</given-names></name> <name><surname>Yamaguchi</surname> <given-names>M.</given-names></name> <name><surname>Shimizu</surname> <given-names>Y.</given-names></name> <name><surname>Ooe</surname> <given-names>K.</given-names></name> <name><surname>Hamada</surname> <given-names>S.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity.</article-title> <source><italic>J. Biol. Chem.</italic></source> <volume>283</volume> <fpage>6253</fpage>&#x2013;<lpage>6260</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M704821200</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trieu-Cuot</surname> <given-names>P.</given-names></name> <name><surname>Carlier</surname> <given-names>C.</given-names></name> <name><surname>Poyart-Salmeron</surname> <given-names>C.</given-names></name> <name><surname>Courvalin</surname> <given-names>P.</given-names></name></person-group> (<year>1991</year>). <article-title>Shuttle vectors containing a multiple cloning site and a lacZ alpha gene for conjugal transfer of DNA from <italic>Escherichia coli</italic> to gram-positive bacteria.</article-title> <source><italic>Gene</italic></source> <volume>102</volume> <fpage>99</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/0378-1119(91)90546-N</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname> <given-names>M. J.</given-names></name> <name><surname>Barnett</surname> <given-names>T. C.</given-names></name> <name><surname>McArthur</surname> <given-names>J. D.</given-names></name> <name><surname>Cole</surname> <given-names>J. N.</given-names></name> <name><surname>Gillen</surname> <given-names>C. M.</given-names></name> <name><surname>Henningham</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Disease manifestations and pathogenic mechanisms of group a <italic>Streptococcus</italic>.</article-title> <source><italic>Clin. Microbiol. Rev.</italic></source> <volume>27</volume> <fpage>264</fpage>&#x2013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00101-13</pub-id></citation></ref>
</ref-list>
</back>
</article>